ArticleBMJ neurology open2026
Study protocol for a prospective, cluster randomised control, hybrid type 1 effectiveness-implementation trial to evaluate the Reduction Of Seizures through Education and Support: the ROSES study.
Article in BMJ neurology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Epilepsy affects 1% of the US population, imposing a significant burden through seizures, distress and medication side effects. Many adverse outcomes can be reduced with patient education and an acute seizure action plan. Electronic health record clinical templates can support this care but are often seen as burdensome. This study will develop a clinical template embedding an acute seizure action plan into routine neurology visits and examine its effect on care quality and healthcare use, as well as barriers and facilitators to adoption. Methods and analysis: This study is a single-site, prospective, quality improvement, hybrid type 1 effectiveness-implementation study, sequential mixed-method design. Providers are randomised to either the acute seizure action plan plus general health education, or general health education alone control group, with 10 patients per provider enrolled over 12-15 months and followed for 1 year. Phase 1 will collect baseline interviews and pre-enrolment seizure outcomes. Phase 2 will implement the intervention with quantitative data along with provider interviews at 6 months. Phase 3 will include 12-month interviews to assess real-world use of the acute seizure action plan. The primary outcome is change in epilepsy quality measure scores before and after implementation between groups. Secondary outcomes include changes in individual quality measures, seizure metrics and healthcare utilisation. Implementation processes will be assessed by the Unified Theory of Acceptance and Use of Technology and Theoretical Domains Framework. Ethics and dissemination: The study was approved by the Yale Institutional Review Board (Protocol ID: 2000032913). Findings will be disseminated through peer-reviewed publications and conference presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.